Effectiveness of biological disease-modifying antirheumatic drugs in progressive pulmonary fibrosis associated with rheumatoid arthritis

Ryuichiro Kanda, Yoshiya Tanaka, Yusuke Miyazaki, Satoshi Kubo, Midori Ueno, Takako Kawaguchi, Shunsuke Fukuyo, Ippei Miyagawa, Ayako Yamaguchi, Yurie Satoh-Kanda, Naoaki Ohkubo, Yasuyuki Todoroki, Masanobu Ueno, Yuya Fujita, Katsuhide Kusaka, Hidenori Sakai, Shunpei Kosaka, Satsuki Matsunaga, Hirotsugu Nohara, Kazuhiro Yatera, Takatoshi Aoki, Shingo Nakayamada

Open source

DOI
10.1093/rheumatology/keag421
Published
2026-08-20
Container
Rheumatology
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keag421,
  title = {Effectiveness of biological disease-modifying antirheumatic drugs in progressive pulmonary fibrosis associated with rheumatoid arthritis},
  author = {Ryuichiro Kanda and Yoshiya Tanaka and Yusuke Miyazaki and Satoshi Kubo and Midori Ueno and Takako Kawaguchi and Shunsuke Fukuyo and Ippei Miyagawa and Ayako Yamaguchi and Yurie Satoh-Kanda and Naoaki Ohkubo and Yasuyuki Todoroki and Masanobu Ueno and Yuya Fujita and Katsuhide Kusaka and Hidenori Sakai and Shunpei Kosaka and Satsuki Matsunaga and Hirotsugu Nohara and Kazuhiro Yatera and Takatoshi Aoki and Shingo Nakayamada},
  year = {2026},
  journal = {Rheumatology},
  doi = {10.1093/rheumatology/keag421},
  url = {https://doi.org/10.1093/rheumatology/keag421}
}

RIS

TY  - JOUR
TI  - Effectiveness of biological disease-modifying antirheumatic drugs in progressive pulmonary fibrosis associated with rheumatoid arthritis
AU  - Ryuichiro Kanda
AU  - Yoshiya Tanaka
AU  - Yusuke Miyazaki
AU  - Satoshi Kubo
AU  - Midori Ueno
AU  - Takako Kawaguchi
AU  - Shunsuke Fukuyo
AU  - Ippei Miyagawa
AU  - Ayako Yamaguchi
AU  - Yurie Satoh-Kanda
AU  - Naoaki Ohkubo
AU  - Yasuyuki Todoroki
AU  - Masanobu Ueno
AU  - Yuya Fujita
AU  - Katsuhide Kusaka
AU  - Hidenori Sakai
AU  - Shunpei Kosaka
AU  - Satsuki Matsunaga
AU  - Hirotsugu Nohara
AU  - Kazuhiro Yatera
AU  - Takatoshi Aoki
AU  - Shingo Nakayamada
PY  - 2026
JO  - Rheumatology
DO  - 10.1093/rheumatology/keag421
UR  - https://doi.org/10.1093/rheumatology/keag421
ER  - 

APA

Kanda, R., Tanaka, Y., Miyazaki, Y., Kubo, S., Ueno, M., Kawaguchi, T., Fukuyo, S., Miyagawa, I., Yamaguchi, A., Satoh-Kanda, Y., Ohkubo, N., Todoroki, Y., Ueno, M., Fujita, Y., Kusaka, K., Sakai, H., Kosaka, S., Matsunaga, S., Nohara, H., Yatera, K., Aoki, T., & Nakayamada, S. (2026). Effectiveness of biological disease-modifying antirheumatic drugs in progressive pulmonary fibrosis associated with rheumatoid arthritis. Rheumatology. https://doi.org/10.1093/rheumatology/keag421

Source records